PortfoliosLab logoPortfoliosLab logo
V vs. ABBV
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

V vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Visa Inc. (V) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, V achieves a -7.36% return, which is significantly lower than ABBV's 1.08% return. Over the past 10 years, V has underperformed ABBV with an annualized return of 15.72%, while ABBV has yielded a comparatively higher 18.45% annualized return.


V

1D
1.06%
1M
1.71%
YTD
-7.36%
6M
-1.91%
1Y
-11.08%
3Y*
13.20%
5Y*
7.86%
10Y*
15.72%

ABBV

1D
1.02%
1M
10.83%
YTD
1.08%
6M
2.16%
1Y
25.16%
3Y*
23.16%
5Y*
19.52%
10Y*
18.45%
*Multi-year figures are annualized to reflect compound growth (CAGR)

V vs. ABBV - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
V
Visa Inc.
-7.36%11.76%22.32%26.31%-3.40%-0.31%17.12%43.33%16.49%47.18%
ABBV
AbbVie Inc.
1.08%33.08%18.86%-0.23%24.01%32.43%27.72%1.47%-0.96%60.07%

Correlation

The correlation between V and ABBV is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.21

Correlation (3Y)
Calculated over the trailing 3-year period

0.27

Correlation (5Y)
Calculated over the trailing 5-year period

0.27

Correlation (10Y)
Calculated over the trailing 10-year period

0.31

Correlation (All Time)
Calculated using the full available price history since Jan 3, 2013

0.33

The correlation between V and ABBV shifts across timeframes, from 0.21 (1 year) to 0.33 (all time), reflecting how their relationship changes across market environments.

Fundamentals

EPS

V:

$15.24

ABBV:

$2.05

PE Ratio

V:

21.23

ABBV:

110.71

PS Ratio

V:

10.97

ABBV:

6.41

Total Revenue (TTM)

V:

$43.03B

ABBV:

$62.82B

Gross Profit (TTM)

V:

$16.94B

ABBV:

$46.15B

EBITDA (TTM)

V:

$27.63B

ABBV:

$17.96B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

V vs. ABBV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

V
V Risk / Return Rank: 2020
Overall Rank
V Sharpe Ratio Rank: 2020
Sharpe Ratio Rank
V Sortino Ratio Rank: 1818
Sortino Ratio Rank
V Omega Ratio Rank: 1818
Omega Ratio Rank
V Calmar Ratio Rank: 2222
Calmar Ratio Rank
V Martin Ratio Rank: 2121
Martin Ratio Rank

ABBV
ABBV Risk / Return Rank: 6868
Overall Rank
ABBV Sharpe Ratio Rank: 7373
Sharpe Ratio Rank
ABBV Sortino Ratio Rank: 6767
Sortino Ratio Rank
ABBV Omega Ratio Rank: 6565
Omega Ratio Rank
ABBV Calmar Ratio Rank: 6868
Calmar Ratio Rank
ABBV Martin Ratio Rank: 6868
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

V vs. ABBV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Visa Inc. (V) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


VABBVDifference
Sharpe ratioReturn per unit of total volatility

-1.54

Sortino ratioReturn per unit of downside risk

-2.16

Omega ratioGain probability vs. loss probability

0.93

1.20

-0.27

Calmar ratioReturn relative to maximum drawdown

-0.55

1.46

-2.01

Martin ratioReturn relative to average drawdown

-1.01

3.27

-4.28

V vs. ABBV - Sharpe Ratio Comparison

The current V Sharpe Ratio is -0.50, which is lower than the ABBV Sharpe Ratio of 1.04. The chart below compares the historical Sharpe Ratios of V and ABBV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


VABBVDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.50

1.04

-1.54

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.35

0.86

-0.51

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.64

0.72

-0.07

Sharpe Ratio (All Time)

Calculated using the full available price history

0.69

0.75

-0.06

Drawdowns

V vs. ABBV - Drawdown Comparison

The maximum V drawdown since its inception was -51.90%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for V and ABBV.


Loading charts...

Drawdown Indicators


VABBVDifference

Max Drawdown

Largest peak-to-trough decline

-51.90%

-45.09%

-6.81%

Max Drawdown (1Y)

Largest decline over 1 year

-20.38%

-17.32%

-3.06%

Max Drawdown (3Y)

Largest decline over 3 years

-20.38%

-20.74%

+0.36%

Max Drawdown (5Y)

Largest decline over 5 years

-28.60%

-21.92%

-6.68%

Max Drawdown (10Y)

Largest decline over 10 years

-36.36%

-45.09%

+8.73%

Current Drawdown

Current decline from peak

-12.64%

-4.81%

-7.83%

Average Drawdown

Average peak-to-trough decline

-8.26%

-10.72%

+2.46%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.00%

7.71%

+3.29%

Volatility

V vs. ABBV - Volatility Comparison

The current volatility for Visa Inc. (V) is 5.65%, while AbbVie Inc. (ABBV) has a volatility of 6.15%. This indicates that V experiences smaller price fluctuations and is considered to be less risky than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


VABBVDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.65%

6.15%

-0.50%

Volatility (6M)

Calculated over the trailing 6-month period

17.47%

17.80%

-0.33%

Volatility (1Y)

Calculated over the trailing 1-year period

22.27%

24.23%

-1.96%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

22.79%

22.89%

-0.10%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

24.46%

25.74%

-1.28%

Dividends

V vs. ABBV - Dividend Comparison

V's dividend yield for the trailing twelve months is around 0.80%, less than ABBV's 2.97% yield.


PositionTTM20252024202320222021202020192018201720162015
ABBV
AbbVie Inc.
2.97%2.87%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%
V
Visa Inc.
0.80%0.70%0.68%0.72%0.76%0.62%0.56%0.56%0.67%0.61%0.75%0.64%

Financials

V vs. ABBV - Financials Comparison

This section allows you to compare key financial metrics between Visa Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


6.00B8.00B10.00B12.00B14.00B16.00B20222023202420252026
11.23B
15.00B
(V) Total Revenue
(ABBV) Total Revenue
Values in USD except per share items

V vs. ABBV - Profitability Comparison

The chart below illustrates the profitability comparison between Visa Inc. and AbbVie Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-50.0%0.0%50.0%100.0%20222023202420252026
-79.3%
83.5%
Portfolio components
V - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Visa Inc. reported a gross profit of -8.90B and revenue of 11.23B. Therefore, the gross margin over that period was -79.3%.

ABBV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a gross profit of 12.53B and revenue of 15.00B. Therefore, the gross margin over that period was 83.5%.

V - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Visa Inc. reported an operating income of 7.23B and revenue of 11.23B, resulting in an operating margin of 64.4%.

ABBV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported an operating income of 4.73B and revenue of 15.00B, resulting in an operating margin of 31.6%.

V - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Visa Inc. reported a net income of 6.02B and revenue of 11.23B, resulting in a net margin of 53.6%.

ABBV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a net income of 699.00M and revenue of 15.00B, resulting in a net margin of 4.7%.


Frequently Asked Questions


V and ABBV have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ABBV has higher volatility (6.15%) compared to V (5.65%). In terms of maximum drawdown, V dropped -51.90% vs ABBV's -45.09%.

ABBV currently has the higher Sharpe Ratio (1.04 vs -0.50), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for V and ABBV

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer